Vascular Disease Devices Market Size (USD 51.80 billion by 2030) Achieves Record-breaking Growth in Meeting Healthcare Requirements

Allied Market Research published a report, titled, “Vascular Disease Devices Market by Product (Stents, Balloons, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Others), and End User (Hospitals and Cardiac Centers, and Ambulatory Surgical Center): Global Opportunity Analysis and Industry Forecast, 2021–2030.” According to the report, the global vascular disease devices industry generated USD 26.52 billion in 2020 and is expected to reach USD 51.80 billion by 2030, witnessing a CAGR of 6.5% from 2021 to 2030.

The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

Covid-19 Scenario: –

• The global vascular disease devices market has been impacted negatively during the pandemic due to partial or complete stoppage of manufacturing activities, disruptions in supply chain, and reduced demand for devices.
• The Covid-19 pandemic led to surge in number of Covid-infected patients in hospitals and put a pressure on the healthcare system. Many vascular disease surgeries were postponed and this reduced the demand for vascular disease devices market.
• Advancements in vascular devices and enhanced healthcare infrastructure is expected to boost the growth of the vascular disease devices market post-pandemic.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞:  https://www.alliedmarketresearch.com/request-sample/15951

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭?

Rise in prevalence of cardiovascular diseases and surge in number of diabetes and hypertension patients drive the growth of the global vascular disease devices market. However, product recall and failure hinder the market growth. On the other hand, R&D activities in vascular diseases present new opportunities in the coming years.

Top Vascular Disease Devices Companies

• Medtronic
• Boston Scientific Corporation
• Abbott Laboratories
• Becton Dickinson and Company
• Terumo Corporation
• Cordis
• Braun Melsungen Ag
• Ivascular
• Merit Medical
• Koninklijke Philips N.V.

𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐜𝐚𝐧 𝐛𝐞 𝐝𝐨𝐧𝐞 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐟𝐚𝐜𝐭𝐨𝐫𝐬, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠:

Based on product type, the stents segment held the highest share in 2020, accounting for more than two-fifths of the global vascular disease devices market, and is estimated to continue its lead position during the forecast period. This is attributed to increased cardiovascular surgeries and rise in number of hospitals. However, the balloons segment is estimated to witness the fastest CAGR of 7.9% from 2021 to 2030, owing to rise in demand of balloons for angioplasty.

Based on end user, the hospitals and cardiac centers segment accounted for the highest share in 2020, contributing to more than four-fifths of the global vascular disease devices market, and is estimated to maintain its leadership status throughout the forecast period. This is due to increase in number of hospitals & clinics and rise in cardio vascular diseases. However, the ambulatory surgical centers segment is expected to manifest the fastest CAGR of 7.2% from 2021 to 2030. This is attributed to surge in number of ambulatory surgery centers and the impact of Covid-19 pandemic.

Based on region, North America contributed to the highest market share in 2020, holding around two-fifths of the global vascular disease devices market, and is expected to maintain its dominance by 2030. This is attributed to rise in the prevalence of coronary diseases, presence of key players for manufacturing & development of vascular devices, and increase in number of hospitals in the region. However, Europe is estimated to portray the largest CAGR of 6.7% during the forecast period, owing to rise in number of hospitals, presence of good healthcare infrastructures, and government initiatives for coronary surgeries.

Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/15951

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook 

• North America
  (U.S., Canada, Mexico)
• Europe
  (Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
  (Japan, China, India, Rest of Asia-Pacific)
• LAMEA
  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.